ADRA2C Antikörper (C-Term)
Kurzübersicht für ADRA2C Antikörper (C-Term) (ABIN1721453)
Target
Alle ADRA2C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 442-462, C-Term
-
Spezifität
- Reacts with s human and mouse Alpha-2C adrenergic receptor.
-
Aufreinigung
- Purified
-
Immunogen
- Synthetic peptide corresponding to aa 442-462 (QDFRRSFFKHILFRRRRRGFQ), the cytoplasmic C-terminus, of human Alpha-2C adrenergic receptor
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB 1 μg/mL ICC1:10-1:2000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Andere Bezeichnung
- alpha-2C Adrenergic Receptor
-
Hintergrund
- Alpha-2C adrenergic receptor Alpha-2 adrenergic receptor subtype C4 Alpha-2C adrenoreceptor, Alpha-2C adrenoceptor, Alpha-2CAR Gene name: ADRA2C, ADRA2L2, ADRA2RL2
-
Gen-ID
- 152
-
UniProt
- P18825
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-